PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23725836-0	2013	Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2.	epigallocatechin gallate	15-19	angiopoietin 1	Mus musculus	143-148	
23725836-4	2013	METHODS AND RESULTS: EGCG treatment of A549 cells in mice bearing xenografts in vivo led to a significant decrease of MVD detected by CD31, and of Ang-2 expression detected by quantum dots double-label immunofluorescence assessment, while Ang-1 decreased with no significance.	epigallocatechin gallate	21-25	angiopoietin 1	Mus musculus	239-244	
23725836-9	2013	CONCLUSION: IFP and delivery of oxygen might be improved by rebalance of Ang-1/Ang-2 under the treatment of EGCG in NSCLC, which also acts as a sensitizer of chemotherapy.	epigallocatechin gallate	108-112	angiopoietin 1	Mus musculus	73-78